Fabrice Valette

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.

Journal: RMD open
Published: January 12, 2024

Modulation of autoimmune diabetes by N-ethyl-N-nitrosourea- induced mutations in non-obese diabetic mice.

Modulation of autoimmune diabetes by N-ethyl-N-nitrosourea- induced mutations in non-obese diabetic mice.

Journal: Disease models & mechanisms
Published: January 25, 2022

De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.

De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2021

Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.

Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.

Journal: Transplantation
Published: May 15, 2018

A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice.

A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice.

Journal: Diabetologia
Published: January 29, 2018

Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

Journal: Diabetologia
Published: March 10, 2017

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4+ T cells.

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4+ T cells.

Journal: Frontiers in immunology
Published: November 16, 2016

Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.

Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.

Journal: Journal of autoimmunity
Published: May 25, 2016

Correction: Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes.

Correction: Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes.

Journal: PloS one
Published: January 23, 2016

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance.

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance.

Journal: eLife
Published: April 15, 2015

Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance.

Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 26, 2014

Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.

Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.

Journal: PloS one
Published: September 21, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026